John Pitcher, MD
Ophthalmology · Albuquerque, NMNPI 1538312582
Payments from drug & device makers
Across 1,060 payments — averaging $2494.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron$584K
- Genentech, Inc.$459K
- Ocular Therapeutix, Inc.$252K
- Bayer$241K
- Apellis Pharmaceuticals, Inc.$203K
- Boehringer Ingelheim$181K
- plus $726K from 19 others
Across 17 payments — averaging $1278.34 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Ocular Therapeutix, Inc.$10K
- F. Hoffmann-la Roche AG$7K
- Regeneron$5K
What the payments were for
- Consulting fees$86,69028%
- Speaking & faculty fees$190,07662%
- Travel & lodging$24,3658%
- Food & beverage$5,6612%
- Education$430%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron | 354 | $583,544 |
| Genentech, Inc. | 113 | $458,646 |
| Ocular Therapeutix, Inc. | 22 | $251,549 |
| Bayer | 107 | $240,994 |
| Apellis Pharmaceuticals, Inc. | 73 | $202,656 |
| Boehringer Ingelheim | 13 | $180,804 |
| Regeneron Healthcare Solutions, Inc. | 101 | $175,484 |
| Kyowa Kirin, Inc. | 77 | $172,110 |
| Alcon Research LLC | 4 | $98,850 |
| Genentech USA, Inc. | 78 | $92,122 |
| Hexal AG | 18 | $78,918 |
| Roche TCRC, Inc. | 4 | $42,466 |
| AbbVie(2 entities) | 17 | $31,961 |
| Novartis | 20 | $28,195 |
| Boehringer Ingelheim International GmbH | 42 | $3,739 |
| Oyster Point Pharma, Inc. | 1 | $2,080 |
| Alcon | 5 | $185 |
| Alimera Sciences, Inc. | 1 | $94 |
| Amgen | 2 | $71 |
| AstraZeneca | 1 | $43 |
| Biogen | 2 | $41 |
| Astellas Pharma US Inc | 2 | $31 |
| Bausch & Lomb Americas Inc. | 1 | $24 |
| Spark Therapeutics, Inc. | 1 | $18 |
| Halozyme Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,644,640 in reported general payments places this provider in the 95th percentile of 81 ophthalmology providers in New Mexico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 272 | $9,366 |
| Cyclosporine | 13 | $3,149 |
| Latanoprost | 180 | $2,488 |
| Ketorolac Tromethamine | 69 | $2,193 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 82 | $1,756 |
| Brimonidine Tartrate | 148 | $1,485 |
| Difluprednate | 12 | $1,148 |
| Polymyxin B Sul-TrimethoprimPolymyxin B Sulf/Trimethoprim | 120 | $1,110 |
| Dorzolamide Hcl | 54 | $991 |
| Timolol Maleate | 82 | $909 |
| Ofloxacin | 32 | $389 |
| ErythromycinErythromycin Base | 12 | $156 |
| Prednisone | 26 | $146 |
| Diclofenac Sodium | 13 | $121 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Albuquerque
- Robert MelendezAlbuquerque$766K
- Mark ChiuAlbuquerque$736K
- Arup DasAlbuquerque$449K
- Frank MaresAlbuquerque$117K
- Iuri GolubevAlbuquerque$62K
- Christopher RoybalAlbuquerque$58K
- Barbara MarshAlbuquerque$53K
- Stephen ColemanAlbuquerque$48K
- Kenneth HimmelAlbuquerque$21K
- Gregory OgawaAlbuquerque$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.